2 days MCK Stock Down Despite Latest Partnership to Boost SCD TreatmentZacks
The availability of the FDA-approved drug via McKesson’s cell and gene therapies business is expected to give patients improved treatment options for SCD.
Business · McKesson (MCK) · Pharmaceuticals · Vertex (VRTX)
X